Zainal Hafisyatul, Rolf Andreas, Zhou Hui, Vasquez Moises, Escher Felicitas, Keller Till, Vasa-Nicotera Mariuca, Zeiher Andreas M, Schultheiss Heinz-Peter, Nagel Eike, Puntmann Valentina O
Institute of Experimental and Translational Cardiac Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt, Frankfurt am Main, Germany; Department of Cardiology, Universiti Teknologi MARA (UiTM), Selangor, Malaysia.
Department of Cardiology, Kerckhoff Clinic, University Giessen, Bad Nauheim, Germany.
J Cardiovasc Magn Reson. 2024;26(2):101087. doi: 10.1016/j.jocmr.2024.101087. Epub 2024 Aug 25.
Myocardial inflammation is increasingly detected noninvasively by tissue mapping with cardiovascular magnetic resonance (CMR). Intraindividual agreement with endomyocardial biopsy (EMB) or markers of myocardial injury, high-sensitive cardiac troponin (hs-cTnT) in patients with clinically suspected viral myocarditis is incompletely understood.
Prospective multicenter study of consecutive patients with clinically suspected myocarditis who underwent blood testing for hs-cTnT, CMR, and EMB as a part of diagnostic workup. EMB was considered positive based on immunohistological criteria in line with the European Society of Cardiology (ESC) definitions. CMR diagnoses employed tissue mapping using sequence-specific cut-off for native T1 and T2 mapping; active inflammation was defined as T1 ≥2 standard deviation (SD) and T2 ≥2 SD above the mean of normal range. Hs-cTnT of greater than 13.9 ng/L was considered significant.
A total of 114 patients (age (mean ± SD) 54 ± 16, 65% males) were included, of which 79 (69%) had positive EMB criteria, 64 (56%) CMR criteria, and a total of 58 (51%) positive troponin. Agreement between EMB and CMR diagnostic criteria was poor (CMR vs ESC: area under the curve (AUC): 0.51 (0.39-0.62)). The agreement between a significant hs-cTnT rise and CMR-based diagnosis of myocarditis was good (AUC: 0.84 (0.68-0.92); p < 0.001), but poor for EMB (0.50 (0.40-0.61). Hs-cTnT was significantly associated with native T1 and T2, high-sensitive C-reactive protein, and N-terminal pro-hormone brain natriuretic peptide (r = 0.37, r = 0.35, r = 0.30, r = 0.25; p < 0.001), but not immunohistochemical criteria or viral presence.
In clinically suspected viral myocarditis, all diagnostic approaches reflect the pathophysiological elements of myocardial inflammation; however, the differing underlying drivers only partially overlap. The EMB and CMR diagnostic algorithms are neither interchangeable in terms of interpretation of myocardial inflammation nor in their relationship with myocardial injury.
通过心血管磁共振(CMR)组织成像越来越多地能无创检测到心肌炎症。对于临床疑似病毒性心肌炎患者,心肌内膜活检(EMB)或心肌损伤标志物高敏心肌肌钙蛋白(hs-cTnT)的个体内一致性尚未完全明确。
对连续的临床疑似心肌炎患者进行前瞻性多中心研究,这些患者在诊断检查中接受了hs-cTnT血液检测、CMR和EMB检查。根据符合欧洲心脏病学会(ESC)定义的免疫组织学标准,EMB被视为阳性。CMR诊断采用针对天然T1和T2成像的序列特异性临界值进行组织成像;活动性炎症定义为T1≥正常范围均值以上2个标准差(SD)且T2≥2 SD。Hs-cTnT大于13.9 ng/L被认为具有显著性。
共纳入114例患者(年龄(均值±标准差)54±16岁,65%为男性),其中79例(69%)符合EMB阳性标准,64例(56%)符合CMR标准,总共58例(51%)肌钙蛋白阳性。EMB和CMR诊断标准之间的一致性较差(CMR与ESC:曲线下面积(AUC):0.51(0.39 - 0.62))。hs-cTnT显著升高与基于CMR的心肌炎诊断之间的一致性良好(AUC:0.84(0.68 - 0.92);p < 0.001),但与EMB的一致性较差(0.50(0.40 - 0.61))。Hs-cTnT与天然T1和T2、高敏C反应蛋白以及N末端脑钠肽前体显著相关(r = 0.37,r = 0.35,r = 0.30,r = 0.25;p < 0.001),但与免疫组织化学标准或病毒存在情况无关。
在临床疑似病毒性心肌炎中,所有诊断方法都反映了心肌炎症的病理生理要素;然而,不同的潜在驱动因素仅部分重叠。EMB和CMR诊断算法在心肌炎症的解读方面以及它们与心肌损伤的关系方面都不可互换。